About Rhine Biogenics Private Limited
Data last updated:
Rhine Biogenics Private Limited is a private limited company based in Palghat, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 October 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2003PTC016519. Its GSTIN is 32AACCR6760P1ZY (Kerala). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.97 Cr. It is led by directors including Tirunilayi Krishnan Venugopal (Managing Director) and Ajith Sukumaran Nair.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21/555 (3) Adithya Nagar East Vennakkara Nurani Post Office, Palghat, Kerala, India – 678004.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.2 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹6.16 Cr (net margin 11.6%) and EBITDA of ₹10.34 Cr (EBITDA margin 19.4%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 12% over five years.
The company has about 47 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Rhine Biogenics. As per MCA filings, the company has open charges of ₹1.37 Cr and satisfied charges of ₹2.79 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rhinebiogenics.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address21/555 (3) Adithya Nagar East Vennakkara Nurani Post Office, Palghat, Kerala, India – 678004
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Rhine Biogenics Private Limited
Rhine Biogenics operates one associated brand: Rhine Biogenics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Rhine Biogenics is a pharmaceutical company specializing in dermatological and therapeutic products like creams, lotions, and serums. | rhinebiogenics.com |
Business Activity of Rhine Biogenics Private Limited
The main business activity of Rhine Biogenics is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rhine Biogenics Private Limited FY 2025 filings available
Rhine Biogenics Private Limited reported revenue of ₹53.2 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Rhine Biogenics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 11% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rhine Biogenics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.34 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.16 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rhine Biogenics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rhine Biogenics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rhine Biogenics Private Limited
Rhine Biogenics has 10 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajith Sukumaran Nair | Director | 17 Nov 2003 | 22 Years 11 Months | Current |
| Reji Joy | Director | 17 Nov 2003 | 22 Years 11 Months | Current |
| Ajitkumar Warrior | Director | 08 Oct 2003 | 23 Years 0 Months | Current |
| Jayakumar Narayanan Nair | Director | 17 Nov 2003 | 22 Years 11 Months | Current |
| Peter Jose Ansal Parriathcherry | Director | 17 Nov 2003 | 22 Years 11 Months | Current |
| Kallungal Unni Jothish | Director | 17 Nov 2003 | 22 Years 11 Months | Current |
Peer Comparison of Rhine Biogenics Private Limited
Rhine Biogenics Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adroit Biomed Limited | ₹53.89 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Shivam Medicos Private Limited | ₹53.81 Cr (FY 2024) | •••• | •••• | 35.0% | •••• | Delhi, India |
| Lila Sales and Marketing Private Limited | ₹53.7 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | Kolkata, West Bengal, India |
| Synchem Pharmaceuticals Private Limited | ₹53.59 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Indore, Madhya Pradesh, India |
| Dhana Lakshmi Private Limited | ₹53.41 Cr (FY 2022) | •••• | •••• | 35.0% | •••• | Manipur, India |
| Rhine Biogenics Private Limited this company | ₹53.2 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Palghat, Kerala, India |
| Amrita Pharma Private Limited | ₹53.09 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Bangalore, Karnataka, India |
| Indian Drug Distributors Private Limited | ₹53.01 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| B A & Brothers (Eastern) Private Ltd | ₹52.64 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Kolkata, West Bengal, India |
| Muthu Pharmacy Private Limited | ₹52.25 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Chennai, Tamil Nadu, India |
| Kaustubha Scientific Research Laboratory Private Limited | ₹52.21 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Rhine Biogenics by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rhine Biogenics Private Limited
Rhine Biogenics Private Limited is audited by V.VENUGOPALAN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V.VENUGOPALAN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rhine Biogenics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rhine Biogenics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Sep 2022 | Others | ₹26 Lakh | Open |
| 14 Jul 2022 | Others | ₹10 Lakh | Open |
| 04 Mar 2022 | Hdfc Bank Limited | ₹42 Lakh | Open |
| 31 Dec 2021 | Hdfc Bank Limited | ₹42 Lakh | Open |
| 06 Nov 2019 | Axis Bank Limited | ₹17.24 Lakh | Open |
Total charge records: 13 View all charges
Legal Cases of Rhine Biogenics Private Limited
Rhine Biogenics Private Limited has 6 court cases on record: 5 filed by Rhine Biogenics, 1 filed against it. 1 case is pending and 5 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 1 | 1 |
| District courts | 2 | 0 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Anr | Pending |
| District court, Ernakulam, Kerala | Court case (RCP) | Filed by the company against an individual | Disposed |
| High Court of Kerala | Writ petition | Filed by the company against Assistant Commissioner (Assessment) | Disposed |
| High Court of Kerala | Writ petition | Filed by the company against an individual | Disposed |
| District court, Kozhikode, Kerala | Criminal complaint | Filed by the company against Vivekandnda Travales Pvt | Disposed |
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Rhine Biogenics Private Limited
Rhine Biogenics Private Limited has a workforce of 47 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Rhine Biogenics Private Limited
Rhine Biogenics has 1 subsidiary company and 2 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Rhine Life Sciences Private Limited | U24232KL2006PTC019505 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Rhine Biogenics Private Limited
Rhine Biogenics Private Limited has 11 board changes on record since 2003: 10 appointments and 1 cessation. The latest: Pallipuram Ranganathan Sreeram ceased to be Director on 28 Dec 2007.
25 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Rhine Biogenics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rhine Biogenics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rhine Biogenics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rhine Biogenics Private Limited
Rhine Biogenics has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AACCR6760P1ZY | Kerala | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rhine Biogenics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rhine Biogenics Private Limited
Rhine Biogenics is an active private limited company based in Palghat, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 October 2003 (23+ years old) and is registered under CIN U24232KL2003PTC016519.
Rhine Biogenics reported revenue of ₹53.2 Cr for FY 2025 (up 11% YoY).
Rhine Biogenics has 10 current directors:
- Tirunilayi Krishnan Venugopal - Managing Director
- Ajith Sukumaran Nair - Director
- Reji Joy - Director
- Ajitkumar Warrior - Director
- Jayakumar Narayanan Nair - Director
- Peter Jose Ansal Parriathcherry - Director
- Kallungal Unni Jothish - Director
- Vinod Menon Kumar - Director
- Madathiveetil Ramesh - Director
- Pudugrammam Krishna Iyer Vaidyanathan - Director
Rhine Biogenics reported a net profit of ₹6.16 Cr (net margin 11.6%) and EBITDA of ₹10.34 Cr (EBITDA margin 19.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rhine Biogenics is 11% over three years and 12% over five years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rhine Biogenics is 32AACCR6760P1ZY, registered in Kerala. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Rhine Biogenics is U24232KL2003PTC016519. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rhine Biogenics has 6 court cases on record: 5 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Rhine Biogenics was incorporated on 08 October 2003, making it 23+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Rhine Biogenics by revenue are Adroit Biomed Limited, Shivam Medicos Private Limited, Lila Sales and Marketing Private Limited, Synchem Pharmaceuticals Private Limited, Dhana Lakshmi Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Pallipuram Ranganathan Sreeram ceased to be Director on 28 Dec 2007. Vinod Menon Kumar was appointed as Director on 01 Aug 2004. Ajith Sukumaran Nair was appointed as Director on 17 Nov 2003. Rhine Biogenics has 11 board changes on record in total.